PMID

Data

Article Title

Organization

o-phenylphenols: potent and orally active leukotriene B4 receptor antagonists.

Eli Lilly

trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor.

Pfizer

Discovery of novel and potent leukotriene B4 receptor antagonists. Part 1.

Roche Research Center

 

2-alkyl-4-ethyl-5-[6-methyl-6-(2H-tetrazol-5-yl)heptyloxy]phenol leukotriene B₄ receptor antagonists

TBA

 

Ortho-alkoxyphenol leukotriene B4 receptor antagonists: effect of a chroman carboxylic acid.

TBA

Discovery of Irbesartan Derivatives as BLT2 Agonists by Virtual Screening.

Fraunhofer Institute For Translational Medicine and Phamacology Itmp

First Structure-Activity Relationship Study of Potent BLT2 Agonists as Potential Wound-Healing Promoters.

Fraunhofer Ime

Elucidation of Mechanism for Ligand Efficacy at Leukotriene B

Incerebro

Biphenylyl-substituted xanthones: highly potent leukotriene B4 receptor antagonists.

Eli Lilly

Antileukotrienic N-arylethyl-2-arylacetamides in the treatment of ulcerative colitis.

Zentiva Vufb

Synthesis and structure-activity relationships of new 1, 3-disubstituted cyclohexanes as structurally rigid leukotriene B(4) receptor antagonists.

Cnrs 5074

Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease.

Yogi Vemana University

Inhibition of guinea pig aldehyde oxidase activity by different flavonoid compounds: An in vitro study.

Kermanshah University of Medical Sciences

Phosphorylation of Capsaicinoid Derivatives Provides Highly Potent and Selective Inhibitors of the Transcription Factor STAT5b.

University of Leipzig